These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 23259900)
1. Uterine metastasis of lobular breast cancer during adjuvant letrozole therapy. Komeda S; Furukawa N; Kasai T; Washida A; Kobayashi H J Obstet Gynaecol; 2013 Jan; 33(1):99-101. PubMed ID: 23259900 [No Abstract] [Full Text] [Related]
2. Durable remission of leptomeningeal metastasis of breast cancer with letrozole: a case report and implications of biomarkers on treatment selection. Ozdogan M; Samur M; Bozcuk HS; Sagtas E; Yildiz M; Artac M; Savas B Jpn J Clin Oncol; 2003 May; 33(5):229-31. PubMed ID: 12865466 [TBL] [Abstract][Full Text] [Related]
3. Solitary uterine metastasis of invasive lobular carcinoma after adjuvant endocrine therapy: a case report. Toyoshima M; Iwahashi H; Shima T; Hayasaka A; Kudo T; Makino H; Igeta S; Matsuura R; Ishigaki N; Akagi K; Sakurada J; Suzuki H; Yoshinaga K J Med Case Rep; 2015 Feb; 9():47. PubMed ID: 25881005 [TBL] [Abstract][Full Text] [Related]
4. Invasive lobular carcinoma: response to neoadjuvant letrozole therapy. Dixon JM; Renshaw L; Dixon J; Thomas J Breast Cancer Res Treat; 2011 Dec; 130(3):871-7. PubMed ID: 21870129 [TBL] [Abstract][Full Text] [Related]
5. Abnormal cervical smear: a sign of disseminated breast cancer. Lince SL; Douma J; Wiersma-Van Tilburg AJ; Kraayenbrink AA Eur J Obstet Gynecol Reprod Biol; 2008 Dec; 141(2):186-7. PubMed ID: 18768248 [No Abstract] [Full Text] [Related]
6. Metastasis of lobular breast carcinoma to the uterus in a patient under anastrozole therapy. Ustaalioglu BB; Bilici A; Seker M; Salman T; Gumus M; Barisik NO; Salepci T; Yaylaci M Onkologie; 2009 Jul; 32(7):424-6. PubMed ID: 19556822 [TBL] [Abstract][Full Text] [Related]
7. Letrozole improves disease-free survival vs tamoxifen in adjuvant treatment of early breast cancer. Oncology (Williston Park); 2005 Mar; 19(3):277, 360. PubMed ID: 15828547 [No Abstract] [Full Text] [Related]
8. Lobular carcinoma of the breast metastasizing to leiomyoma in a patient under letrozole treatment. Işçi H; Güdücü N; Basgul AY; Aydinli K; Calay Z; Dünder I Eur J Gynaecol Oncol; 2011; 32(5):560-2. PubMed ID: 22053676 [TBL] [Abstract][Full Text] [Related]
9. Letrozole as adjuvant therapy for postmenopausal women with early breast cancer. Russell CA Manag Care Interface; 2007 Sep; 20(9):30-1, 36. PubMed ID: 18161388 [No Abstract] [Full Text] [Related]
10. Rectal metastasis from lobular carcinoma of the breast: a case report. Balja MP; Vrdoljak DV; Stanec M; Sitić S; Supić DK; Knezević F Coll Antropol; 2010 Jun; 34(2):719-21. PubMed ID: 20698161 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness of a letter notification program for women with early-stage breast cancer eligible for extended adjuvant letrozole. McArthur HL; Gelmon KA; Olivotto IA; Speers CH; Ellard SL; O'Reilly SE; Kennecke HF J Clin Oncol; 2009 Mar; 27(9):1388-93. PubMed ID: 19237634 [TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in hormone receptor-positive postmenopausal women with early-stage breast cancer. Delea TE; Karnon J; Sofrygin O; Thomas SK; Papo NL; Barghout V Clin Breast Cancer; 2007 Jun; 7(8):608-18. PubMed ID: 17592673 [TBL] [Abstract][Full Text] [Related]
13. Huge response to letrozole in inoperable T4 breast cancer: a case report. Di Cosimo S; Altomare V; Ferretti G; Gravante G; Rabitti C; Rea F; Arullani A; D'Aprile M Clin Ter; 2001; 152(4):263-5. PubMed ID: 11725620 [TBL] [Abstract][Full Text] [Related]
14. Letrozole suppresses plasma estradiol and estrone sulphate more completely than anastrozole in postmenopausal women with breast cancer. Dixon JM; Renshaw L; Young O; Murray J; Macaskill EJ; McHugh M; Folkerd E; Cameron DA; A'Hern RP; Dowsett M J Clin Oncol; 2008 Apr; 26(10):1671-6. PubMed ID: 18375896 [TBL] [Abstract][Full Text] [Related]
15. Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17. Perez EA; Josse RG; Pritchard KI; Ingle JN; Martino S; Findlay BP; Shenkier TN; Tozer RG; Palmer MJ; Shepherd LE; Liu S; Tu D; Goss PE J Clin Oncol; 2006 Aug; 24(22):3629-35. PubMed ID: 16822845 [TBL] [Abstract][Full Text] [Related]
16. Orbital fat regeneration following hormonal treatment of metastatic breast carcinoma. Alameddine RM; Ko AC; Mimura M; Parker BA; Lin JH; Korn BS; Kikkawa DO Orbit; 2018 Jun; 37(3):187-190. PubMed ID: 29072521 [TBL] [Abstract][Full Text] [Related]
17. Letrozole in the extended adjuvant treatment of postmenopausal women with history of early-stage breast cancer who have completed 5 years of adjuvant tamoxifen. Mann BS; Johnson JR; Kelly R; Sridhara R; Williams G; Pazdur R Clin Cancer Res; 2005 Aug; 11(16):5671-7. PubMed ID: 16115902 [TBL] [Abstract][Full Text] [Related]
18. A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. Goss PE; Ingle JN; Martino S; Robert NJ; Muss HB; Piccart MJ; Castiglione M; Tu D; Shepherd LE; Pritchard KI; Livingston RB; Davidson NE; Norton L; Perez EA; Abrams JS; Therasse P; Palmer MJ; Pater JL N Engl J Med; 2003 Nov; 349(19):1793-802. PubMed ID: 14551341 [TBL] [Abstract][Full Text] [Related]
19. Effects of the antiestrogen tamoxifen and the aromatase inhibitor letrozole on serum hormones and bone characteristics in a preclinical tumor model for breast cancer. Núñez NP; Jelovac D; Macedo L; Berrigan D; Perkins SN; Hursting SD; Barrett JC; Brodie A Clin Cancer Res; 2004 Aug; 10(16):5375-80. PubMed ID: 15328175 [TBL] [Abstract][Full Text] [Related]
20. Excellent response to letrozole in brain metastases from breast cancer. Goyal S; Puri T; Julka PK; Rath GK Acta Neurochir (Wien); 2008 Jun; 150(6):613-4; discussion 614-5. PubMed ID: 18458809 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]